netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.05.01  Expand sub section  Preparations for eczema
Alitretinoin caps

View adult BNF  View SPC online
Formulary
High Cost Medicine
Red

Link  NICE TA177: Eczema (chronic) - alitretinoin    
Mycophenolate mofetil tabs, caps

View adult BNF  View SPC online
Formulary
Amber 3
Approved off-label indications:
  • Severe immunobullous disease
  • Severe atopic dermatitis
  • Severe psoriasis
    Reasons for prescribing should be clearly communicated to the patient’s GP
    Restricted to use in patients patients unresponsive or intolerant of standard therapies. Use as a steroid-sparing immunosuppressant
  •    
    Zinc paste and ichthammol bandage BP (Ichthopaste®)

    View adult BNF  View SPC online
    Formulary
       
    Zinc paste bandage BP (Viscopaste PB7®)

    View adult BNF  View SPC online
    Formulary
       
    Propaderm ointment 1 in 10 (beclometasone dipropionate 0.0025%)

    View adult BNF  View SPC online
    Restricted Drug Unlicensed Used as a wet wrap in treatment of eczema in children
       
     ....
    Key
    note Notes First Choice Item First Choice item
    Section Title Section Title (top level) Non Formulary Item Non Formulary section
    Section Title Section Title (sub level)
    Cytotoxic Drug
    Cytotoxic Drug
    Restricted Drug
    Restricted Drug
    CD
    Controlled Drug
    Unlicensed Drug
    Unlicensed
    High Cost Medicine
    High Cost Medicine
    click to search medicines.org.uk
    Link to SPCs
    click to search medicines.org.uk
    Link to adult BNF
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Cancer Drugs Fund
    Cancer Drugs Fund
       

     

    Traffic Light Status Information

    Status Description
      Red   Specialist Prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   
      Amber 1   Treatment can be initiated in primary care after a recommendation from an appropriate specialist  
      Amber 2   Specialist initiation followed by maintenance prescribing in primary care  
      Amber 3   Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  
      Green   Specialist and non-specialist initiation  
      Grey   Not recommended for prescribing  

    netFormulary